This website uses cookies to ensure you have the best user experience. By continuing to use this website, you consent to our use of cookies. For more information, read our privacy policy.
Clonal hematopoiesis as a biomarker of poor prognosis in high-grade serous ovarian cancer
Using population-based data to understand ovarian cancer care and outcomes in Nova Scotia
